Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Inari Medical, Inc. (NARI)
|
Add to portfolio |
|
|
|
| Price: |
$92.76
| | Metrics |
| OS: |
57.4
|
M
| |
|
|
| Market cap: |
$5.32
|
B
| |
|
|
|
Net cash:
|
$338
|
M
| |
$5.89
|
per share
|
|
EV:
|
$4.98
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-05-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 383.5 | 383.5 | 277.0 | 277.0 | 139.7 | 139.7 | 51.1 | 6,828.8 |
| Revenue growth | 38.4% | 38.4% | 98.3% | 98.3% | 173.2% | | -99.3% | |
| Cost of goods sold | 44.5 | 44.5 | 24.8 | 24.8 | 13.1 | 13.1 | 5.9 | 1,280.5 |
| Gross profit | 339.0 | 339.0 | 252.2 | 252.2 | 126.6 | 126.6 | 45.2 | 5,548.3 |
| Gross margin | 88.4% | 88.4% | 91.1% | 91.1% | 90.6% | 90.6% | 88.4% | 81.2% |
| Selling, general and administrative | 367.1 | 292.8 | 241.4 | 190.4 | 108.1 | 89.7 | 44.4 | 10,697.9 |
| Research and development | | 74.2 | | 51.0 | | 18.4 | | 3,989.8 |
| EBIT | -26.2 | -28.1 | 10.7 | 10.8 | 17.1 | 18.4 | 0.7 | -9,139.4 |
| EBIT margin | -6.8% | -7.3% | 3.9% | 3.9% | 12.2% | 13.2% | 1.4% | -133.8% |
| Pre-tax income | -26.2 | -26.2 | 10.7 | 10.7 | 13.8 | 13.8 | -1.2 | 0.0 |
| Income taxes | 3.1 | 3.1 | 0.8 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 7.9% | 7.9% | 0.0% | 0.0% | 0.0% | |
| Net income | -29.3 | -29.3 | 9.8 | 9.8 | 13.8 | 13.8 | -1.2 | 0.0 |
| Net margin | -7.6% | -7.6% | 3.6% | 3.6% | 9.9% | 9.9% | -2.3% | 0.0% |
| |
| Diluted EPS | ($0.55) | ($0.55) | $0.18 | $0.18 | $0.27 | $0.27 | ($0.20) | $0.00 |
| Shares outstanding (diluted) | 52.8 | 52.8 | 55.6 | 55.6 | 51.6 | 51.6 | 5.9 | 5,056.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|